Rare Diseases and Orphan Drugs Growth Favorable to Specialty Pharmacies

Biophama companies are increasingly interested in establishing relationships with  experienced specialty pharmacies to dispense rare disease drugs to patients

ACA Supreme Court Deliberations and Any Impact on Biosimilars?

If the court strikes down the ACA entirely, biosimilars on the U.S. market or in the FDA approval pipeline would have to either be grandfathered in or face a regulatory wind-down

Conduent Joins with Experian Health to Expand Patient Assistance Capabilities

Conduent has resources and expertise to process millions of documents or transactions across a range of industries and works with patient enrollment, benefits verification and prior authorization paperwork

MyWalgreens Revamped to Accelerate the Company’s Digital Transformation

Walgreens interacts with approximately 8 million customers in its stores and online each day and has more than 90 million Balance Rewards members

CareMetx, LLC’s OutcomeRx Launches a Reinsurance Product for Cell and Gene Therapies

OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements

AccentCare and Seasons Hospice Merger to Reshape Home Care and Hospice Market

AccentCare, owned by Advent International, is among the five largest home health providers in the country. Seasons Hospice holds the same distinction in the U.S. hospice market. The merger will expand the combined company’s geographic footprint and portfolio of services. AccentCare delivers home health, hospice, personal care and care management services to more than 145,000 […]